Coronavirus RSS Page 14

Filtered By:
Countries: Spain Health

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 2505 results found since Jan 2013.

Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors
This study investigated the association between serological biomarkers at hospital admission with the development of long-term post-COVID pain symptoms in previously hospitalized coronavirus disease, 2019 (COVID-19) survivors. A cohort study including patients hospitalised because of COVID-19 in 1 urban hospital of Madrid (Spain) during the first wave of the outbreak was conducted. Hospitalisation data, clinical data, and 11 serological biomarkers were collected at hospital admission. Participants were scheduled for an individual telephone interview after hospital discharge for collecting data about post-COVID pain symptom...
Source: Pain - October 20, 2022 Category: Anesthesiology Tags: Clinical Note Source Type: research

Risk and prognostic factors for SARS-CoV-2 infection in Spanish population with multiple sclerosis during the first five waves
ConclusionThe incidence of COVID-19 was similar in this MS cohort to the general population. Smoking halved the risk of being infected. Higher EDSS and pulmonary comorbidity were associated with an increased risk of severe forms.
Source: Frontiers in Neurology - October 19, 2022 Category: Neurology Source Type: research

Viruses, Vol. 14, Pages 2284: Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 Inhabitants
Conclusions: Among the patients hospitalised because of COVID-19, complete vaccination was associated with less severe forms of COVID-19, with an earlier discharge date. Age and haematological disease were related to a higher mortality rate during the first 30 days of hospitalisation.
Source: Viruses - October 17, 2022 Category: Virology Authors: Jos é M. Ruiz-Giardin Marta Rivilla Nieves Mesa Alejandro Morales Luis Rivas A ída Izquierdo Almudena Escrib á Juan V. San Mart ín David Bernal-Bello Elena Madro ñal Ana I. Farf án Marta Guerrero Ruth Calder ón Miguel A. Duarte Sara I. Piedrabuena Tags: Article Source Type: research

A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain
This study analyses the seroprevalence variation of SARS-CoV-2 in stray cats from different waves of outbreaks in a geographical area where previous seroepidemiological information of SARS-CoV-2 was available and investigate if SARS-CoV-2-seropositive cats were exposed to other co-infections causing an immunosuppressive status and/or a chronic disease that could lead to a SARS-CoV-2 susceptibility. For this purpose, a total of 254 stray cats from Zaragoza (Spain) were included. This analysis was carried out by the enzyme-linked immunosorbent assay using the receptor binding domain of Spike antigen and confirmed by serum vi...
Source: Veterinary Research Communications - October 14, 2022 Category: Veterinary Research Source Type: research

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Lancet Respir Med. 2022 Oct 10:S2213-2600(22)00298-3. doi: 10.1016/S2213-2600(22)00298-3. Online ahead of print.ABSTRACTBACKGROUND: COVID-19 disease is accompanied by a dysregulated immune response and hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with the combination of rivaroxaban and aspirin for prevention of disease progression in patients hospitalised with COVID-19.METHODS: The ACT inpatient, open-label, 2 × 2 factorial, randomised, controlled trial was done at 62 clinical centres in 11 countries. Patient...
Source: Respiratory Care - October 13, 2022 Category: Respiratory Medicine Authors: John W Eikelboom Sanjit S Jolly Emilie P Belley-Cote Richard P Whitlock Sumathy Rangarajan Lizhen Xu Laura Heenan Shrikant I Bangdiwala Maria Luz Diaz Rafael Diaz Afzalhussein Yusufali Sanjib Kumar Sharma Wadea M Tarhuni Mohamed Hassany Alvaro Avezum Will Source Type: research

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Lancet Respir Med. 2022 Oct 10:S2213-2600(22)00299-5. doi: 10.1016/S2213-2600(22)00299-5. Online ahead of print.ABSTRACTBACKGROUND: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) outpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with aspirin for prevention of disease progression in community patients with COVID-19.METHODS: The ACT outpatient, open-label, 2 × 2 factorial, randomised, controlled trial, was done at 48 clinical sites in 11 countries. Patients in th...
Source: Respiratory Care - October 13, 2022 Category: Respiratory Medicine Authors: John W Eikelboom Sanjit S Jolly Emilie P Belley-Cote Richard P Whitlock Sumathy Rangarajan Lizhen Xu Laura Heenan Shrikant I Bangdiwala Wadea M Tarhuni Mohamed Hassany Anna Kontsevaya William Harper Sanjib Kumar Sharma Patricio Lopez-Jaramillo Antonio L D Source Type: research

MIF is a Common Genetic Determinant of COVID-19 Symptomatic Infection and Severity
CONCLUSIONS: In this multinational retrospective study of 1171 subjects with COVID-19, the commonly occurring -794 CATT7 MIF allele is associated with reduced susceptibility to symptomatic SARS-CoV-2 infection but increased disease progression as assessed by hospitalization. These findings affirm the importance of host genetics in different stages of COVID-19 infection.PMID:36222594 | DOI:10.1093/qjmed/hcac234
Source: Cancer Control - October 12, 2022 Category: Cancer & Oncology Authors: Junghee J Shin Wei Fan Jennefer Par-Young Marta Piecychna Lin Leng Kavita Israni-Winger Hua Qing Jianlei Gu Hongyu Zhao Wade L Schulz Serhan Unlu John Kuster Grant Young Jian Liu Albert I Ko Alvaro Baeza Garcia Maor Sauler Adam V Wisnewski Lawrence Young Source Type: research

Adaptive immunity to SARS-CoV-2 infection: A systematic review
ConclusionsIt is concluded that through this study it is possible to have a brief overview of the main immunological biomarkers and their function during SARS-CoV-2 infection in particular cell types. In critically ill individuals, adaptive immunity is varied, aberrantly compromised, and late. In particular, the T-cell response is also an essential and necessary component in immunological memory and therefore should be addressed in vaccine formulation strategies.
Source: Frontiers in Immunology - October 10, 2022 Category: Allergy & Immunology Source Type: research

The COVID-19 pandemic effect on the prehospital Madrid stroke code metrics and diagnostic accuracy
by Nicol ás Riera-López, Andrea Gaetano-Gil, José Martínez-Gómez, Nuria Rodríguez-Rodil, Borja M. Fernández-Félix, Jorge Rodríguez-Pardo, Carmen Cuadrado-Hernández, Emmanuel Pelayo Martínez-González, Alicia Villar-Arias, Fátima Gutiérrez-Sánchez, Pablo Busca-Ostolaza, Eduardo Montero-Ruiz, Exu perio Díez-Tejedor, Javier Zamora, Blanca Fuentes-Gimeno, on behalf of the Madrid Stroke Network BackgroundOnly very few studies have investigated the effect of the COVID-19 pandemic on the pre-hospital stroke code protocol. During the first wave, Spain was one of the most affected countries by the SARS-CoV-2 coronavi...
Source: PLoS One - October 10, 2022 Category: Biomedical Science Authors: Nicol ás Riera-López Source Type: research

Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children.PMID:36169886 | PMC:PMC9514983 | DOI:10.1007/s12519-022-00617-2
Source: World Journal of Pediatrics : WJP - September 28, 2022 Category: Pediatrics Authors: Elisa Garc ía-García Mercedes Rodr íguez-Pérez David P érez-Solís Carlos P érez-Méndez Cristina Molinos-Norniella Ángeles Cobo-Ruisánchez Eva Mar ía Fernández Fernández Noelia Garc ía González Laura Calle-Miguel Source Type: research

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection and Humoral Responses Against Different Variants of Concern in Domestic Pet Animals and Stray Cats from North-Eastern Spain
This article is protected by copyright. All rights reserved.PMID:36167932 | DOI:10.1111/tbed.14714
Source: Emerging Infectious Diseases - September 28, 2022 Category: Infectious Diseases Authors: Leira Fern ández-Bastit Silvia Marfil Edwards Pradenas Rosa Valle N úria Roca Jordi Rodon Lola Pailler-Garc ía Benjamin Trinit é Mariona Parera Marc Noguera-Julian Jaume Martorell Nuria Izquierdo-Useros Jorge Carrillo Bonaventura Clotet Juli à Blanco Source Type: research

Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children.PMID:36169886 | DOI:10.1007/s12519-022-00617-2
Source: World Journal of Pediatrics : WJP - September 28, 2022 Category: Pediatrics Authors: Elisa Garc ía-García Mercedes Rodr íguez-Pérez David P érez-Solís Carlos P érez-Méndez Cristina Molinos-Norniella Ángeles Cobo-Ruisánchez Eva Mar ía Fernández Fernández Noelia Garc ía González Laura Calle-Miguel Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20